| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |